2m 2m 2m 2m 2m 2m 2m
CRESCENT BIOPHAR (CBIO)
NASDAQ
$19.37-$0.05 (-0.23%)
Price as of Sep 11, 2026 7:30 PM EDT- $292.5MMarket Cap
- 55.40%1-Year Change
- BiotechnologyIndustry
CRESCENT BIOPHAR (CBIO)
$19.37-$0.05 (-0.23%)
Earnings Score
Valuation | CBIO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -2 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CBIO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -8.72% | ||
12-Month Momentum | 30.92% | ||
3-Month Risk Adjusted Momentum | -29.81% | ||
12-Month Risk Adjusted Momentum | 40.50% |
True Yield
Valuation | CBIO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.002% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CBIO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -5 |